Understanding how DNAJ proteins affect muscle diseases
Elucidating the Role of DNAJ Proteins in Muscle Disease
This study is looking at how certain proteins called DNAJ help fix other proteins that are not shaped right, which can cause muscle diseases, and it hopes to find new ways to treat these conditions that currently have no cure.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11081795 on NIH RePORTER |
What this research studies
This research investigates the role of DNAJ proteins in muscle diseases caused by misfolded proteins, known as chaperonopathies. It aims to understand how these proteins interact with and help fold other proteins correctly, which is crucial for muscle health. The study will utilize advanced techniques such as proteomics and small animal imaging to explore the specific client proteins of DNAJ proteins and their impact on muscle function. By identifying the mechanisms behind muscle degeneration, the research seeks to uncover potential therapeutic targets for these currently untreatable conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with muscle diseases related to chaperonopathies, particularly those with mutations in DNAJ proteins.
Not a fit: Patients with muscle diseases not linked to protein misfolding or those without genetic mutations in DNAJ proteins may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for muscle diseases caused by protein misfolding.
How similar studies have performed: While the specific focus on DNAJ proteins in muscle diseases is relatively novel, similar research on protein misfolding has shown promise in other contexts.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Inoue, Michio — Washington University
- Study coordinator: Inoue, Michio
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.